Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 34 studies | 35% ± 16% | |
glutamatergic neuron | 13 studies | 49% ± 26% | |
endothelial cell of artery | 12 studies | 30% ± 19% | |
oligodendrocyte precursor cell | 12 studies | 38% ± 14% | |
microglial cell | 11 studies | 27% ± 8% | |
astrocyte | 10 studies | 28% ± 14% | |
GABAergic neuron | 9 studies | 41% ± 22% | |
retinal rod cell | 9 studies | 41% ± 17% | |
endothelial cell of lymphatic vessel | 9 studies | 45% ± 18% | |
oligodendrocyte | 9 studies | 25% ± 11% | |
macrophage | 7 studies | 30% ± 8% | |
retinal cone cell | 7 studies | 42% ± 11% | |
vein endothelial cell | 7 studies | 35% ± 21% | |
B cell | 6 studies | 21% ± 7% | |
neuron | 6 studies | 38% ± 16% | |
interneuron | 6 studies | 42% ± 15% | |
dendritic cell | 6 studies | 22% ± 5% | |
myeloid cell | 6 studies | 20% ± 4% | |
epithelial cell | 5 studies | 30% ± 9% | |
mast cell | 5 studies | 25% ± 6% | |
endothelial cell of vascular tree | 5 studies | 33% ± 18% | |
granule cell | 4 studies | 36% ± 10% | |
capillary endothelial cell | 4 studies | 31% ± 13% | |
adipocyte | 4 studies | 17% ± 2% | |
cardiac muscle cell | 4 studies | 25% ± 2% | |
lymphocyte | 4 studies | 23% ± 6% | |
monocyte | 4 studies | 31% ± 5% | |
T cell | 4 studies | 20% ± 3% | |
classical monocyte | 3 studies | 21% ± 4% | |
hematopoietic precursor cell | 3 studies | 36% ± 14% | |
pericyte | 3 studies | 20% ± 2% | |
GABAergic interneuron | 3 studies | 30% ± 6% | |
retinal bipolar neuron | 3 studies | 23% ± 8% | |
GABAergic amacrine cell | 3 studies | 25% ± 7% | |
glycinergic amacrine cell | 3 studies | 27% ± 5% | |
alveolar macrophage | 3 studies | 27% ± 6% | |
natural killer cell | 3 studies | 18% ± 2% | |
type I pneumocyte | 3 studies | 20% ± 3% | |
type II pneumocyte | 3 studies | 20% ± 3% | |
goblet cell | 3 studies | 29% ± 13% | |
smooth muscle cell | 3 studies | 21% ± 0% | |
fibroblast | 3 studies | 17% ± 2% | |
plasmacytoid dendritic cell | 3 studies | 22% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 886.38 | 244 / 245 | 100% | 15.90 | 500 / 502 |
thymus | 100% | 2297.73 | 653 / 653 | 99% | 27.32 | 600 / 605 |
breast | 100% | 1016.19 | 459 / 459 | 98% | 19.64 | 1098 / 1118 |
lung | 100% | 1496.87 | 578 / 578 | 98% | 10.47 | 1133 / 1155 |
pancreas | 100% | 748.98 | 327 / 328 | 98% | 10.81 | 175 / 178 |
liver | 100% | 673.77 | 226 / 226 | 98% | 9.35 | 396 / 406 |
brain | 99% | 863.37 | 2608 / 2642 | 99% | 8.28 | 696 / 705 |
stomach | 100% | 656.83 | 358 / 359 | 98% | 11.17 | 279 / 286 |
intestine | 100% | 1039.87 | 966 / 966 | 97% | 11.80 | 510 / 527 |
bladder | 100% | 1051.24 | 21 / 21 | 96% | 9.37 | 484 / 504 |
esophagus | 98% | 749.88 | 1422 / 1445 | 96% | 9.93 | 175 / 183 |
uterus | 100% | 829.73 | 170 / 170 | 94% | 8.51 | 431 / 459 |
kidney | 100% | 621.21 | 89 / 89 | 94% | 8.20 | 845 / 901 |
adrenal gland | 100% | 1906.30 | 258 / 258 | 93% | 10.40 | 215 / 230 |
ovary | 99% | 538.57 | 178 / 180 | 87% | 5.60 | 376 / 430 |
skin | 90% | 518.53 | 1626 / 1809 | 86% | 7.46 | 405 / 472 |
adipose | 100% | 1185.48 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 9.09 | 29 / 29 |
spleen | 100% | 1386.49 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.74 | 1 / 1 |
muscle | 100% | 1810.85 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 895.23 | 1332 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 6.61 | 43 / 45 |
heart | 95% | 542.05 | 817 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 1555.37 | 866 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 28% | 1.30 | 22 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0090522 | Biological process | vesicle tethering involved in exocytosis |
GO_0006904 | Biological process | vesicle docking involved in exocytosis |
GO_0006886 | Biological process | intracellular protein transport |
GO_0006887 | Biological process | exocytosis |
GO_0000281 | Biological process | mitotic cytokinesis |
GO_0006893 | Biological process | Golgi to plasma membrane transport |
GO_0090148 | Biological process | membrane fission |
GO_0090543 | Cellular component | Flemming body |
GO_0005829 | Cellular component | cytosol |
GO_0030426 | Cellular component | growth cone |
GO_0005886 | Cellular component | plasma membrane |
GO_0000145 | Cellular component | exocyst |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | EXOC6 |
Protein name | Exocyst complex component Exocyst complex component 6 (Exocyst complex component Sec15A) (SEC15-like protein 1) Exocyst complex component 6 |
Synonyms | SEC15L1 SEC15A SEC15L |
Description | FUNCTION: Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane. Together with RAB11A, RAB3IP, RAB8A, PARD3, PRKCI, ANXA2, CDC42 and DNMBP promotes transcytosis of PODXL to the apical membrane initiation sites (AMIS), apical surface formation and lumenogenesis (By similarity). . FUNCTION: Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane. . |
Accessions | B1AP46 ENST00000495132.5 F2Z3K0 ENST00000260762.10 [Q8TAG9-1] Q8TAG9 ENST00000443748.6 E7EW84 ENST00000371552.8 [Q8TAG9-2] ENST00000371543.5 H0Y5J8 ENST00000458552.1 ENST00000672817.1 [Q8TAG9-2] ENST00000671701.1 [Q8TAG9-2] |